In addition, tumor-infiltrating Treg cells express a small amount of Il2ra(CD25), a TCR-mediated activation marker46, which competitively binds IL-2, thereby inhibiting the activity of other effector T cells and exerting immunosuppressive function. The gene discussed is IL2RA; the disease is neoplasm.